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Abstract
 
The asymmetric disposition of T cell receptor (TCR) C
 
 
 
 and C
 
 
 
 ectodomains creates a cavity
with a side-wall formed by the rigid C
 
 
 
 FG loop. To investigate the significance of this con-
served structure, we generated loop deletion (
 
  
 
FG) and 
 
 
 
wt transgenic (tg) mice using the
TCR 
 
 
 
 subunit of the N15 CTL. N15
 
 
 
wt and N15
 
  
 
FG H-2
 
b
 
 animals have comparable
numbers of thymocytes in S phase and manifest developmental progression through the
CD4
 
 
 
CD8
 
 
 
 double-negative (DN) compartment. N15
 
  
 
FG facilitates transition from DN to
CD4
 
 
 
8
 
 
 
 double-positive (DP) thymocytes in recombinase activating gene (RAG)-2
 
 
 
/
 
 
 
 mice,
showing that pre-TCR function remains. N15
 
  
 
FG animals possess 
 
 
 
twofold more CD8
 
 
 
single-positive (SP) thymocytes and lymph node T cells, consistent with enhanced positive se-
lection. As an altered V
 
 
 
 repertoire observed in N15
 
  
 
FG mice may confound the deletion’s
effect, we crossed N15
 
  
 
 TCR tg RAG-2
 
 
 
/
 
 
 
 with N15
 
  
 
FG tg RAG-2
 
 
 
/
 
 
 
 H-2
 
b
 
 mice to
generate N15
 
  
 
 RAG-2
 
 
 
/
 
 
 
 and N15
 
  
 
.
 
  
 
FG RAG-2
 
 
 
/
 
 
 
 littermates. N15
 
  
 
.
 
  
 
FG
RAG-2
 
 
 
/
 
 
 
 mice show an 8–10-fold increase in DP thymocytes due to reduced negative selec-
tion, as evidenced by diminished constitutive and cognate peptide-induced apoptosis. Com-
pared with N15
 
  
 
, N15
 
  
 
.
 
  
 
FG T cells respond poorly to cognate antigens and weak ago-
nists. Thus, the C
 
 
 
 FG loop facilitates negative selection of thymocytes and activation of T cells.
Key words: negative selection • thymocyte development • TCR structure • Ig superfamily • 
transgenic mice
 
Introduction
 
The TCR is a multicomponent complex composed of a Ti
disulfide-linked heterodimer in noncovalent association
with the CD3 subunits (1–5). The majority of T cells ex-
press a Ti-encoded by 
 
 
 
 and 
 
 
 
 TCR genes (Ti
 
  
 
) whereas
a numerically minor but functionally significant subset ex-
pressed Ti encoded by 
 
 
 
 and 
 
 
 
 TCR genes (Ti
 
  
 
; for a re-
view, see reference 6). The Ti
 
  
 
 heterodimer whose over-
all shape and architecture are similar to an antibody Fab
fragment represents the peptide–MHC complex (pMHC)
 
*
 
ligand binding unit. Thus, Ti 
 
  
 
 determines the ligand
specificity of an individual T cell. In contrast, the CD3
polypeptides mediate TCR-based signal transduction. The
signaling function of the CD3 components involves a con-
served motif, termed immunoreceptor tyrosine-based acti-
vation motif (ITAM), present at 1–3 copies in the cytoplas-
mic domain of each CD3 subunit (7–9). The various CD3
subunits exhibit different interactions with intracellular sig-
naling factors and, acting in concert, lead to T cell activa-
tion (10–15). However, how pMHC ligand binding to a
Ti
 
  
 
 or Ti
 
  
 
 heterodimer subsequently initiates signaling
via the CD3 molecules is currently unknown.
The TCR complex contains one copy of CD3
 
 
 
 and
CD3
 
 
 
 and two copies of CD3
 
 
 
 and CD3
 
 
 
 configured as
two CD3
 
  
 
 and CD3
 
  
 
 heterodimers and a disulfide-
linked CD3
 
 
 
 homodimer (16–21). Recent crystallographic
analysis (22) in conjunction with epitope mapping of a class
I–restricted TCR (23) have identified a cavity within the
Ti 
 
  
 
 constant (C) module of sufficient size to accommo-
date one nonglycosylated CD3
 
 
 
 ectodomain. In this re-
gard, the solution structure of a heterodimeric CD3
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ectodomain complex reveals a unique side-to-side hydro-
phobic interface between the two C2-set immunoglobu-
lin-like domains and indicates that a modular pair-wise as-
sociation is shared between CD3
 
  
 
 as well (24). CD3
 
 
 
 has
an elongated shape with length, width and depth being
 
 
 
40, 25, and 25 Å, respectively.
Herein, we have investigated the biological significance
of the unusual structural arrangement of the C
 
 
 
 FG loop
that forms the side wall of this C-module cavity. Mapping
studies using the C
 
 
 
 FG loop-specific mAb H57 previously
showed that one of two CD3
 
 
 
 subunits resides adjacent to
this structural element. To this end, we have created TCR
transgenic mice bearing either intact or C
 
 
 
 FG loop-
deleted 
 
 
 
 chains. Our results show that the loss of the C
 
 
 
 FG
loop attenuates negative selection without blocking posi-
tive selection within the thymus at the level of double-pos-
itive (DP)
 
 
 
thymocytes. The sensitivity of mature T cells to
cognate peptides as well as altered peptide ligands is also re-
duced. In contrast, pre-TCR facilitated transition from
CD44
 
 
 
CD25
 
 
 
 to CD44
 
 
 
CD25
 
 
 
 double-negative (DN)
thymocytes and subsequent DP thymocyte generation is
not altered. The implications of these findings for TCR
and pre-TCR function are discussed.
 
Materials and Methods
 
T Cell Receptor Construct.
 
The FG loop-deleted mutant of the
N15 TCR
 
 
 
 chain constant region (C
 
 
 
) was generated by PCR
using N15
 
 
 
 wt cDNA as a template, subcloned into the pCRII
vector, and verified by DNA sequencing analysis. The StuI di-
gested DNA fragment containing the FG loop-deleted constant
region of the TCR
 
 
 
 chain was subcloned into the StuI site in the
constant region of an N15 TCR
 
 
 
 expression vector, which was
previously used for the generation of N15 TCR
 
  
 
 tg recombi-
nase activating gene (RAG)-2
 
 
 
/
 
 
 
 H-2
 
b
 
 mice (25).
 
Mice.
 
Mice transgenic for the N15 wt or FG loop-deleted
TCR
 
 
 
 chain (hereafter for simplicity referred to as N15
 
 
 
wt or
N15
 
  
 
FG) were produced in the transgenic/gene targeting core
facility at Dana-Farber Cancer Institute. The N15 TCR
 
 
 
 shuttle
constructs with the wt or FG loop-deleted mutant C
 
 
 
 were di-
gested with PvuI/SalI, leaving the bacterial vector sequences at-
tached to the TCR gene. These DNAs were injected into (SJL 
 
 
 
C57BL/6) F1 fertilized eggs and implanted into foster mothers.
Resulting progeny were screened for integration of the N15 wt
or FG loop-deleted TCR
 
 
 
 chain DNA by Southern blot analysis
of tail DNA and by FACS
 
®
 
 analysis of N15 TCR
 
 
 
 chain expres-
sion in peripheral blood nucleated cells. Five transgenic founders
were identified, two for N15
 
 
 
wt, and three for N15
 
  
 
FG. The
mice were backcrossed for 4–5 generations onto the C57BL/6
background before the experiments described below. To create
N15
 
  
 
FG RAG-2
 
 
 
/
 
  
 
mice, the N15  FG mice were bred with
RAG-2 /  C57BL/6 mice and the heterozygous N15  FG / 
RAG-2 /  F1 mice were intercrossed and offspring which
were N15  FG RAG-2 /  subsequently selected. The expres-
sion of the FG loop-deleted N15  chain and lack of RAG-2
were confirmed based on the Southern blot analysis of tail DNA
and FACS® analysis of peripheral blood cells. To introduce the
N15  chain into N15  FG mice and generate Ag-specific T
cells with the FG loop-deleted TCR  chain, the N15  FG
RAG-2 /  (N15  FG / RAG-2 / ) mice were bred with N15
TCR   tg RAG-2 /  H-2b (N15  wt /  wt /  RAG-2 / 
H-2b) mice, and the resulting N15 wt /  wt / RAG-2 /  H-2b
or N15 wt /   wt /   FG / RAG-2 /  H-2b (hereafter for
simplicity referred to as N15   or N15  . FG mice) were used
for the experiments. RAG-2 /  C57BL/6 mice were purchased
from Taconic. All lines were maintained and bred under sterile
barrier conditions at the animal facility of Dana-Farber Cancer
Institute.
Peptide Synthesis. Peptides were synthesized by standard solid
phase methods on an Applied Biosystems 430A synthesizer at the
Biopolymers Laboratory of the Massachusetts Institute of Tech-
nology. All peptides were purified by reverse phase HPLC
(Hewlett Packard HPLC 1100) with a C4, 2-mm column. Pep-
tides were analyzed for purity and correct molecular weight by
electrospray mass spectrometry, amino acid (aa) analysis, and
HPLC. Peptides are named to indicate the substituted aa and the
position in the sequence of VSV8 (e.g., L4 denotes replacement
of valine by leucine at the fourth residue of the VSV8 peptide).
VSV8 is a cognate antigenic peptide agonist of the N15 TCR,
which triggers thymic negative selection in N15 TCR   tg
RAG-2 /  H-2b mice, whereas L4 and K1 peptides are altered
peptide ligands (APLs) of VSV8 and weak agonists of the N15
TCR, which induce positive selection in N15 TCR   tg RAG-
2 /  2M /  H-2b mice (26).
Antibodies and Flow Cytometric Analysis. The following mAbs
were used: R-phycoerythrin (PE)- or Cychrome-conjugated
anti–mouse CD4 (H129.19); FITC- or Cychrome-conjugated
anti–mouse CD8  (53–6.7); Cychrome-conjugated anti-TCR
C  (H57–597); PE-conjugated anti-CD25 (PC61); FITC-conju-
gated anti-CD44 (IM7); FITC-conjugated anti-V 5.1, 5.2
(MR9.4); biotin-conjugated anti-CD69 (H1.2F3); biotin-conju-
gated anti-V 2 (B20.1), anti-V 3.2 (RR3–16), anti-V 8.3
(B21.14), anti-V 11.1, 11.2 (RR8–1), PE-conjugated streptavi-
din (BD PharMingen). For flow cytometry, single cell thymocyte
or lymph node suspensions were prepared in PBS containing 2%
FCS and 0.05% NaN3. Cells were stained at 5   106 cells per ml
in PBS-2% FCS and 0.05% NaN3 containing the antibodies at
saturating concentrations. Phenotypes and proportions of thy-
mocyte and lymph node cell subsets were analyzed by two-color
flow cytometry using a FACScan™ (Becton Dickinson) and the
CELLQuest™ program. Dead cells were excluded from the anal-
ysis by forward and side scatter gating.
Bromodeoxyuridine Staining. Bromodeoxyuridine (BrdU) in-
corporation was examined according to the manufacturer’s pro-
tocol (BrdU Flow Kit; BD PharMingen). Mice were adminis-
tered two intraperitoneal injections of 1 mg of BrdU in PBS at
4 h intervals. After 18 h, thymocytes were fixed/permeabilized
and stained with FITC-conjugated anti-BrdU mAb following
treatment with 30  g/ml DNase. Live cells were gated and ana-
lyzed on a FACScan™.
Apoptosis Assay. Thymocytes from untreated, VSV8 pep-
tide-injected (0.5  g intravenously, 18 h previously) or dexa-
methasone-treated (0.5 mg intraperitoneally, 6 h previously)
were examined. Apoptosis of thymocytes was evaluated by cellu-
lar DNA content determined by propidium iodide (PI) staining
and alterations in plasma membrane permeability examined by
Annexin V staining. For PI staining, after fixation with 40% eth-
anol at 4 C for 30 min, total thymocytes (106 cells) were resus-
pended in PBS containing 50  g/ml RNase A and 2.5  g/ml PI
and incubated at 37 C for 30 min. PI incorporation was analyzed
by flow cytometry. For annexin V staining, after washing with
PBS, total thymocytes (106 cells) were resuspended in 1  bind-
ing buffer containing 0.5  g/ml FITC-conjugated annexin V
(ApoAlert Annexin V Apoptosis kit; CLONTECH Laboratories,1421 Sasada et al.
Inc.) and 2.5  g/ml PI to gate out dead cells, and incubated in
the dark for 10 min at room temperature, followed by the analy-
sis on a FACScan™.
Proliferation Assay. Lymph node cells from N15   or N15  .-
  FG mice (105/well) were incubated at 37 C with 2   104
irradiated EL-4 thymoma cells, which had been preloaded for
2 h with the indicated doses of VSV8 or a weak agonist, L4, in
AIM-V medium (Life Technologies) containing 50  M 2-ME.
After 48 h incubation, 0.4  Ci per well of [3H]TdR (ICN Bio-
medicals) was added, and after an additional 18 h of culture at
37 C, the cells were harvested and the incorporated radioactivity
was measured.
Measurement of IFN- . IFN-  production was induced under
the same culture conditions used for proliferation assays (see
above). After 48 h of incubation, supernatants were collected and
assayed for IFN-  using a mouse IFN-  ELISA kit (Mouse IFN- 
OptEIA Set; BD PharMingen). The sensitivity of the assay was
31.3–2,000 pg/ml and results were calculated as the mean of du-
plicate wells.
Results
The TCR C  FG Loop Structure and Sequence Compari-
son. One remarkable feature of the TCR C  domain is
the striking elongation of the FG loop. Compared with
other Ig-like structures (aside from the TCR C  domain),
there is a 13 aa insertion within the FG loop (27). Fig. 1 A
shows a view of the crystallographically resolved murine
N15 class I MHC-restricted    TCR (V 5.2 D2J 2.6
C 2/V 8 J 5C ; reference 22). The unique protrusion of
the C  domain’s FG loop is apparent (bracketed in a black
box). It was previously noticed that internally the loop is
well structured (22). The Trp225 at the tip of the loop
Figure 1. Structure and sequence analysis of the TCR
C  FG loop region. (A) Structure of the N15  -TCR
heterodimer. The V  and V  variable domains and the
C  and C  constant domains are labeled and the   strands
of C  designated. The uniquely protruding FG loop of
C  is bracketed in a black box. Cysteine residues forming
intradomain disulfide bonds in each of the four domains
are shown in yellow and the four glycosylation sites dis-
cussed in the text are colored in light blue with labels. (B)
A close up view of the region in the black box with the
FG loop and the A and B strands labeled. The view is re-
oriented relative to panel A to best highlight critical side
chains. Note that W225, L219, and P232 of the FG loop
pack onto L119 and V122 to form a mini-hydrophobic
core. See text for a detailed description of this rigid entity.
For clarification, other side chains are not shown with the
exception of cisP154 at the beginning of the BC loop.
Relevant hydrogen bonds are indicated as dashed lines.
Graphics were generated using SETOR (reference 62). (C)
Sequence comparison of the TCR C  FG loop regions
from various species. The position of the F and G strands is
defined based on the above crystallographic analysis. The shaded region defines the 14 aa residue deleted from the N15 TCR   chain. Boxed residues
mark the potential N-linked glycosylation signals. The   chain cysteine (247) which forms an interchain disulfide with the   chain, is indicated by the
semi-solid circle and the F strand cysteine (212) which forms the intradomain disulfide with the   strand cysteine (147) of C  (not shown) is indicated by
the solid circle.1422 C  FG Loop in TCR Function
plays a key role. A hydrogen bond between the NE1 of
Trp225 and the carbonyl group of Ser229 brings the bulky
indole ring of Trp225 in position to make hydrophobic
contacts with Leu219 and Pro232 at the base of the FG
loop (Fig. 1 B, a close up view of the local region shown in
the black box of Fig. 1 A). The hydrophobic patch com-
posed of these three FG loop residues packs onto Leu119
and Val122 at the beginning of the C  domain’s A strand
to form a mini-hydrophobic core. The Leu119 and Val122
themselves lie on a stable local strut created by a tight  
turn between Asp118 and Asn121. Moreover, a pair of
mainchain hydrogen bonds between Thr123 on the A
strand and Phe153 at the end of the B strand further stabi-
lizes the local structure. Collectively, the C  domain FG
loop, albeit a long protrusion, is an integrated component
of a rigid structural entity that connects the V  and C  do-
mains. Not only are the residues mentioned above all in-
variant among mouse, rat, human, chimpanzee, rabbit,
cow, dog, and pig as shown in the Fig. 1 C, but the three-
dimensional structural feature depicted in Fig. 1 B is also
conserved in all known TCR crystal structures, including
class I MHC-restricted N15 and 2C from mouse (22, 28)
and B7 from human (29), as well as the human class II
MHC-restricted HA1.7 (30).
T Lineage Development in N15  FG Mice. To analyze
the role of the C  FG loop in thymocyte development and
mature T cell function in vivo, we established transgenic
mice expressing the wild-type N15 TCR  chain or an FG
loop deletion variant lacking aa 219–232. For simplicity,
these TCR transgenes will be referred to as N15 wt and
N15  FG, respectively. The N15 wt subunit derives
from the N15 CD8  cytotoxic T cell clone whose TCR is
specific for the vesicular stomatitis virus nucleoprotein aa
52–59 (VSV8) (RGYVYQGL) bound to the MHC class I
molecule H-2Kb (31). T lineage cells from the thymus and
lymph nodes of N15  FG mice were then directly com-
pared with those of the N15 wt mice. Fig. 2 A shows a
flow cytometric analysis of CD8  single-positive (SP)
lymph node T cells from 1 of 2 representative N15 wt
lines and 1 of 3 representative N15  FG lines. As ex-
pected, the anti-C  FG loop specific mAb H57 (22, 32)
reacts with virtually all CD8  SP lymph node T cells in
N15 wt tg mice but almost no CD8  SP lymph node T
cells in N15  FG mice. Those few reactive T cells (6.8%)
represent CD8  SP cells that have rearranged endogenous
  chains due to incomplete TCR  chain allelic exclusion
by the N15  transgene, as previously reported in other
transgenic systems (33). Fig. 2 A also indicates that despite
the C  FG loop deletion, N15  FG tg animals, like
N15 wt tg mice, predominantly express the transgenic
V 5.2 gene as detected by the MR9.4 mAb.
Perhaps more importantly, as shown in Fig. 2 B and Ta-
ble I, comparison of thymocyte subsets reveals substantial
differences between the N15 wt and N15  FG tg mice.
At 6–12 wk of age, for example, N15  FG mice show a
subtle but significant reduction in the number of total
thymocytes (N15 wt, 12.05   2.99   107 [ n     10];
N15  FG, 9.51   2.09   107 [n   15], P   0.05; Table
I). Furthermore, as shown by the representative CD4/
CD8  double-staining profiles in Fig. 2 B, there is a de-
tectable increase in the percentage of the CD8  SP subset
and a decrease in that of the DP subset in N15  FG
thymocytes compared with N15 wt mice. Therefore,
N15  FG mice show a statistically significant increase in
the absolute number of CD8  SP thymocytes and a con-
commitant decrease in DP thymocytes (Table I). This in-
crease in CD8  SP cells is further reflected by the increase
in CD8  SP lymph node T cells (N15 wt, 1.99   0.77  
107 [n   10]; N15  FG 3.45   0.82   107 [n   15]).
From these findings, we conclude that the absence of the
FG loop in the constant region of N15 TCR   chain influ-
ences T cell development in the tg mouse model.
There are two major checkpoints at which    thy-
mocyte development is dependent upon the TCR   chain.
The earliest occurs during the transition from DN to DP
thymocytes and is regulated by the pre-TCR complex
Figure 2. Altered phenotypes of T lineage cells in the N15  FG mice.
(A) TCR expression on CD8  SP lymph node T cells in the N15 wt
and N15  FG mice. Lymph node cells from 8-wk-old N15 wt and
N15  FG mice were triple-stained with anti-CD4, anti-CD8, and anti-
TCR C  FG loop specific H57 or anti-V 5 MR9.4 mAbs. The histo-
grams of TCR C  FG loop (left) and V 5 (right) expression on the gated
CD8  SP lymph node T cells are shown. The numbers represent the per-
centages of H57- or V 5-positive cells (as indicated). (B) The CD4/
CD8  double-staining profiles in thymocytes and lymph node cells are
altered by the lack of the TCR C  FG loop. The thymocytes and lymph
node cells from N15 wt and N15  FG mice at 8 wk of age were dou-
ble-stained with PE-anti-CD4 and FITC-anti-CD8 . The expression of
CD4 (y axis) and CD8  (x axis) on thymocytes and lymph node cells was
detected by flow cytometry after gating on 10,000 live cells. The percent-
ages of each subset are indicated.1423 Sasada et al.
comprised of the invariant pT  subunit disulfide linked to
a TCR   chain in noncovalent association with the CD3
subunits (34). The later checkpoint involves the    TCR
and occurs during the transition from DP to SP thymocyte
maturation. At that time, self-MHC–restricted, nonautore-
active T cells are selected for maturation and peripheral ex-
portation (35). To investigate the mechanism of the altered
thymocyte phenotype in N15  FG mice, we first com-
pared early thymic development in the N15 wt and
N15  FG mice by examining the fraction of cells synthe-
sizing DNA using BrdU incorporation in vivo. In this way,
it is possible to test whether the FG loop deletion in the
N15 TCR  chain affects proliferation and/or turnover of
thymocytes. The N15 wt and N15  FG tg mice were in-
jected twice intraperitoneally with 1 mg of BrdU in PBS at
4 h intervals, and 18 h later, thymocytes were assayed for
the incorporation of BrdU by flow cytometry. As shown in
Fig. 3 A, the percentage of BrdU  thymocytes in the
N15  FG mice was comparable to that observed in con-
trol N15 wt mice, indicating that the number of cells that
had progressed through S phase is similar. In addition, we
compared the developmental stages of immature thy-
mocytes by examining the surface expression of CD25 and
CD44 on DN thymocytes of these mice. The percent-
ages of the four CD44/CD25 subsets (CD44 CD25 ,
CD44 CD25 , CD44 CD25 , and CD44 CD25 ) in
the N15  FG were equivalent to those of N15 wt mice
(Fig. 3 B), suggesting that the deletion of C  FG loop from
the N15 TCR  chain does not disrupt the pre-TCR–facil-
itated transition from CD44 CD25  to CD44 CD25 
DN thymocytes. To further assess the function of the
C  FG loop-deletion in pre-TCR signaling at the
CD44 CD25  DN stage, we established RAG-2–deficient
mice expressing the C  FG loop-deleted N15  chain
(N15  FG RAG-2 / ). Introduction of a functionally re-
arranged wild-type TCR  chain overcomes the develop-
mental arrest at the CD44 CD25  DN stage observed in
the RAG-2–deficient mice, leading to strong proliferation
of DN thymocytes and efficient generation of DP cells
(36). As shown in Fig. 3 C, N15  FG RAG-2 /  mice
generate DP thymocytes with essentially normal cellularity
Table I. Absolute Numbers of Total and Cell Subsets of Thymocytes and LN Cells in N15 wt and N15  FG Mice
Thymus LN
Totala DPb CD8  SPa CD4  SP DN Total CD8  SPc CD4  SP
N15 wt 12.05   2.99d 9.95   2.47 0.60   0.17 1.08   0.30 0.41   0.16 6.36   2.11 1.99   0.77 0.49   0.19
N15  FG 9.51   2.09 7.31   1.61 0.85   0.29 1.02   0.27 0.33   0.12 7.17   1.83 3.45   0.82 0.71   0.21
aP   0.05.
bP   0.01.
cP   0.0005.
dThe numbers of cell subsets in thymocytes and lymph node T cells were calculated by quantifying the total number of thymocytes and lymph node
cells from 6–12-wk-old N15  (n   10) and N15  FG (n   15) mice and the percentages of each subset as determined by FACS® analysis. Results
are expressed as mean   SD ( 107 cells). Statistical differences between N15 wt and N15  FG numbers in indicated populations are given.
Figure 3. Early thymocyte de-
velopment is unaffected by the
absence of TCR C  FG loop.
(A) Normal proliferation/turn-
over in N15  FG mice. 9-wk-
old N15 wt and N15  FG
mice were injected intraperito-
neally twice at 4 h intervals with
1 mg of BrdU in 0.2 ml PBS. 18 h
later, thymocytes were stained
with FITC-anti-BrdU mAb and
assayed by flow cytometry. The
histograms of BrdU incorporation on 10,000 live thymocytes are shown.
The numbers represent the percentages of BrdU-positive cells. (B) The
transition from CD44 CD25  to CD44 CD25  DN thymocytes is not
blocked in N15  FG mice. Total thymocytes were triple-stained with
FITC-anti-CD44, PE-anti-CD25, and Cychrome-anti-CD4/anti-
CD8 . The profiles of CD44 (y axis) versus CD25 (x axis) expression in
Cychrome-negative (CD4 CD8  DN) thymocytes are shown. The per-
centage of each subset is indicated. (C) Efficient generation of DP thy-
mocytes in N15  FG RAG-2 /  mice. Thymocytes from 8-wk-old
N15  FG RAG-2 /  mice were double-stained with PE-anti-CD4 and
FITC-anti-CD8 . The expression of CD4 (y axis) and CD8  (x axis) on
thymocytes was detected by flow cytometry after gating on 10,000 live
cells. The percentages of each subset are indicated.1424 C  FG Loop in TCR Function
(6.6   107 thymocytes/mouse). These results suggest that
signaling through the pre-TCR complex on CD44 
CD25  thymocytes is not blocked by the deletion of the
C  FG loop in the N15 TCR  chain.
Altered V  Usages by Peripheral Mature T Cells in the
N15  FG Mice. Given the nearly twofold increase in
the absolute number of CD8  SP lymph node T cells (Ta-
ble I), we next examined whether deletion of the C  FG
loop of the N15   chain influences thymic repertoire selec-
tion. To this end, the TCR V  gene usage of CD8  and
CD4  SP lymph node T cells in N15 wt and N15  FG
mice was assessed by flow cytometry using a panel of anti-
V  mAbs. As shown in Table II, there are statistically sig-
nificant differences in the TCR V  gene usage in periph-
eral lymph node T cells between N15 wt and N15  FG
mice. CD8  lymph node T cells from N15  FG mice dis-
play an increased frequency of TCRs incorporating V 8.3
(mean   4.37%, SD   0.58 versus mean   3.74%, SD  
0.54; P   0.02) and V 11 (mean   6.81%, SD   0.70
versus mean   5.46%, SD   0.50; P   5   10 5) gene
segments compared with N15 wt mice (Table II). CD4 
lymph node T cells from N15  FG mice also bear more
TCRs incorporating V 2 (mean   13.61%, SD   0.95
versus mean   11.77%, SD   1.38; P   0.005) than those
from N15 wt mice. These data suggest that lack of the C 
FG loop exerts an influence on selection of the TCR rep-
ertoire by affecting usage of functional V  gene segments,
leading to the alterations in thymic and peripheral lymph
node phenotypes observed in the N15  FG mice. That
V  differences are observed in CD8  SP thymocytes as
well as lymph node cells is consistent with this view (data
not shown), but does not exclude the possibility that
impaired TCR signaling in the peripheral T cells in
N15  FG animals further alters the repertoire.
Quantitative and Qualitative Alterations of Thymocytes and
Peripheral T Cells in N15  .  FG Mice. The differences
between N15 wt and N15  FG mice may have been
modified by compensatory adaptations of V  gene expres-
sion. To analyze more clearly the role of the TCR C  FG
loop in thymocyte development and mature T cell func-
tion, we next crossed the N15  FG RAG-2 /  mice
(N15  FG / RAG-2 /  H-2b) with N15   tg RAG-
2 /  H-2b (N15 wt /  wt / RAG-2 /  H-2b) to gen-
erate two mouse strains: N15 wt /  wt /  RAG-2 / 
and N15 wt /  wt /   FG / RAG-2 /  mice. These
mice are referred to hereafter for simplicity as N15   and
N15  .  FG, respectively. In these strains, the TCR 
chain is fixed and on the RAG-2 /  background, so no
confounding endogenous   or   chains can be expressed.
T lineage cells from the thymus and lymph nodes of
these animals are directly compared in Fig. 4, A and B. As
defined by the anti-V 5 mAb MR9.4, using quantitative
immunofluorescence on FACS®, the CD8  SP lymph
node T cells from N15  .  FG mice expressed the same
level of N15   chain as CD8  SP T cells derived from
N15   mice. However, the fluorescence intensity of anti-
TCR C  H57 mAb staining in the CD8  SP T cells from
N15  .  FG mice is  50% that in N15   T cells, indi-
cating that CD8  SP T cells from N15  .  FG mice ex-
press both wild-type and FG loop-deleted N15 TCR 
chains complexed with N15 TCR  chains at almost equal
levels on their cell surface (Fig. 4 A). Although not shown,
all peripheral T cells are CD8  SP in both N15   and
N15  .  FG mice with equivalent surface CD8 density
as revealed by the anti-CD8  mAb 53–6.7.
Comparison of the thymocyte cell number and subset
distribution among N15   or N15  .  FG mice reveal
striking differences. At 8–12 wk of age, N15  .  FG
mice have a markedly larger thymus relative to that of
N15   animals with an  sevenfold increase in the number
of total thymocytes (Fig. 4 C). Furthermore, as shown by
the CD4/CD8  double-staining profiles in Fig. 4 B, there
is a substantial increase in the DP subset percentage and a
decrease in the DN and CD8  SP subset percentages
in N15  .  FG thymocytes. As the total number of
N15  .  FG thymocytes is  7 times more than N15  
thymocytes, N15  .  FG mice show no significant dif-
ferences in the absolute numbers of DN and CD8  SP thy-
mocytes, but  10-fold more DP thymocytes than N15  
mice (N15  , 1.48   107 DP cells versus N15  .  FG,
13.2   107 DP cells; Fig. 4 C). These results indicate that
the absence of the TCR C  FG loop influences intrathy-
Table II. V  Usages by CD8  SP and CD4  SP Lymph Node Cells in N15 wt and N15  FG
CD8  SP CD4  SP
V 2V  3.2 V 8.3a V 11b V 2c V 3.2 V 8.3 V 11
N15 wt 12.21   0.95d 1.13   0.43 3.74   0.54 5.46   0.50 11.77   1.38 1.90   0.46 2.00   0.59 5.74   1.54
N15  FG 12.19   0.75 0.99   0.38 4.37   0.58 6.81   0.70 13.61   0.95 1.77   0.58 2.35   0.48 4.74   1.04
aP   0.02.
bP   0.00005.
cP   0.005.
dLymph node cells from 6–12-wk-old N15  (n   10) and N15  FG (n   15) mice were stained with FITC anti-CD4, CyChrome anti-CD8, bi-
otin anti-V  mAb, followed by PE-conjugated streptavidin. Values represent the mean and SD of percentages in CD8  and CD4  SP lymph node
T cell subsets as determined by FACS® analysis.1425 Sasada et al.
mic T cell development in the N15 TCR    tg mouse
system. In contrast to the difference in thymocyte number,
the number of peripheral CD8  SP lymph node T cells
in N15   mice is  2 times more than that in the
N15  .  FG mice (N15  , 1.71   107 cells versus
N15  .  FG, 0.87   107 cells). This difference in pe-
ripheral CD8  SP T cell number may result either from
faulty homeostatic expansion of T cells in the peripheral
lymphoid system of N15  .  FG mice as a consequence
of impaired T cell activation (37) or represent a qualitative
difference in CD8  SP thymocyte maturation and/or re-
lease into the peripheral T cell compartment. CFSE dye
tracking of the CD8  SP transgenic T cells injected into B6
RAG-2 /  mice or irradiated B6 mice excludes detectable
alteration in cell divisions, however (data not shown).
Decreased Thymic Negative Selection in the N15  .  FG
Mice. The T cell repertoire is shaped by both negative and
positive thymic selection processes acting primarily at the
level of the immature DP thymocytes (for reviews, see ref-
erences 35 and 38). Previous studies showed that DP thy-
mocytes are deleted during negative selection via a caspase-
dependent apoptotic mechanism (39). To investigate the
basis for the dramatic increase in DP thymocytes in
N15  .  FG, we evaluated the efficiency of the negative
selection process in the N15   versus N15  .  FG ani-
mals. Apoptotic cells were enumerated through measure-
ment of DNA content in total thymocytes using propidium
iodide and flow cytometric analysis. As shown in Fig. 5 A,
the percentage of thymocytes with subdiploid DNA con-
tent, a typical feature of apoptotic cell death, is significantly
higher in the N15   mice than in the N15  .  FG mice
(N15  , 12.5% versus N15  .  FG, 1.1%). Consistent
with this result, alterations in plasma membrane permeabil-
ity, one of the earliest changes in cells undergoing ap-
optosis, is also altered differentially in N15   versus
N15  .  FG mice. As shown in Fig. 5 B, about half
(48.5%) of the thymocytes in the N15   mice are positive
for annexin V staining, suggesting that a large number of
DP thymocytes are being continuously deleted by apopto-
sis. In contrast, only a small percentage (10.0%) of thy-
mocytes are annexin V positive in N15  .  FG mice.
This finding suggests that the nature of constitutive ongo-
ing negative selection in DP thymocytes is different be-
tween N15   and N15  .  FG mice.
To further probe differences in the negative selec-
tion threshold of DP thymocytes from N15   and
N15  .  FG mice, we injected the cognate peptide
VSV8 intravenously and compared the phenotypic changes
in thymocytes. 18 h after intravenous injection with 0.5  g
of VSV8 peptide, N15   mice showed an  90% reduc-
tion in total thymocyte number (without VSV8 injection,
2.07   107 cells; after VSV8 injection, 0.26   107 cells),
consistent with earlier observations (25). By contrast, there
is no peptide-induced change in the total thymic cellularity
in N15  .  FG mice (without VSV8 injection, 10.4  
107 cells; after VSV8 injection, 10.6   107 cells). These re-
Figure 4. Quantitative and
qualitative T lineage abnormali-
ties in the N15  .  FG mice.
(A) TCR expression on lymph
node T cells in the N15   and
N15  .  FG mice. Lymph
node cells from 12-wk-old
N15   and N15  .  FG mice
were triple-stained with anti-
CD4, anti-CD8, and anti-TCR
C  FG loop-specific H57 or
anti-V 5 MR9.4 mAbs. The
histograms of TCR C  FG loop
(left) and V 5 (right) expression
on the gated CD8  SP lymph
node T cells are shown. The
numbers represent the values of
mean fluorescence intensity. (B)
The CD4/CD8  double-stain-
ing profile in thymocytes is al-
tered in N15  .  FG mice.
The thymocytes from N15  
and N15  .  FG mice at 12
wk of age were double-stained
with PE-anti-CD4 and FITC-
anti-CD8 . The expression of
CD4 (y axis) and CD8  (x axis)
on thymocytes was detected by flow cytometry after gating on 10,000 live cells. The percentages of each subset are indicated. (C) The N15  .  FG
mice show a drastic increase in the total and DP thymocytes, but a decrease in the CD8  SP lymph node T cells. The numbers of total, DP, CD8  SP,
and DN thymocytes and CD8  SP lymph node T cells were calculated by quantifying the total numbers of thymocytes and lymph node cells from 8–12-
wk-old N15   and N15  .  FG mice and the percentages of each subset as determined by FACS® analysis. Open circles (N15   mice [n   13]) and
closed circles (N15  .  FG mice [n   9]) represent values of individual mice and bars represent average values for a given group. The total and DP thy-
mocyte numbers are significantly higher, and CD8  SP lymph node cell number is significantly lower in the N15  .  FG mice, compared with the
N15   mice (total and DP thymocytes, P   0.0001; CD8  SP lymph node cells, P   0.0005).1426 C  FG Loop in TCR Function
sults suggest that deletion of the C  FG loop alters the sen-
sitivity of immature DP thymocytes to negative selection
induced by the cognate peptide in N15 TCRtg mice.
Consistent with the thymic cellularity data, DNA staining
with propidium iodide shows a significant increase in the
percentage of subdiploid DNA-containing cells after
VSV8 injection in the N15   (35.8%) but not in the
N15  .  FG mice (1.3%; Fig. 5 A). Furthermore, as
shown in Fig. 5 B, the N15   mice display a prominent
increase in the annexin V  thymocytes after 18 h of VSV8
(80.4%), compared with N15  .  FG mice (14.7%).
Collectively, these results suggest that the increase in DP
thymocytes in the N15  .  FG mice can be explained, at
least in part, by the reduced sensitivity of those DP thy-
mocytes to undergo peptide-triggered negative selection.
Although not shown, higher doses of VSV8 peptide induce
apoptotic cell death in both N15   and N15  .  FG
thymocytes to a similar extent, suggesting that the
N15  .  FG mice require a larger number of pMHC-
ligated TCRs to trigger negative selection. That dexametha-
sone-induced DNA fragmentation of thymocytes is equiva-
lent in both mouse strains implies no general apoptotic
defect in N15  .  FG animals (data not shown). Note that
the observed apoptosis of thymocytes is not secondary to
peripheral cytokine production observed in other systems
(40) as shown by the rapid kinetics of the N15 TCR tg sys-
tem and prior parallel FTOC analysis (25, 39).
Impaired Proliferation and Cytokine Production upon Antigen-
triggered Stimulation of Naive T Cells in the N15  .  FG
Mice. To examine the role of the C  FG loop in mature
T cell function, we next tested the antigen responsiveness
of N15  .  FG T cells by culturing lymph node T cells
with VSV8 cognate peptide or variant APLs in vitro. To
first address whether the C  FG loop deletion affects early
phases of naive T cell activation, we assessed surface ex-
pression of the cell activation “markers,” IL-2R  (CD25)
and CD69, which represents a reliable method for deter-
mining the number of T cells that are activated in culture
(41, 42). The lymph node T cells from N15   and
N15  .  FG mice were stimulated in vitro for 18 h with
varying molar concentrations of VSV8 or the APL variants,
L4 and K1 (26), using irradiated EL-4 cells as H-2Kb-bear-
ing APCs, and then were assayed for the expression of
CD25 and CD69 by flow cytometry. As shown in Fig. 6 A,
VSV8 peptide was capable of activating virtually almost the
same percentages of T cells at the peptide concentration of
10 4–10 8 M in both N15   and N15  .  FG mice.
However, a very subtle difference is observed in the activa-
tion responses of the N15   and N15  .  FG lymph
node T cells after stimulation with a lower concentration of
VSV8 (10 10 M) and more convincingly with the APLs L4
and K1, as assessed by CD69 (Fig. 6 A) and CD25 (data not
shown) expression. At peptide concentrations of 10 5–10 7 M
for L4 and 10 4–10 5 M for K1, the percentages of acti-
vated T cells from N15   mice are slightly higher than
those from N15  .  FG mice; the dose–response curve
from N15  .  FG lymph node cells after treatment with
L4 or K1 peptide is shifted to the right by a factor of  10.
These findings indicate that in the mature lymphoid com-
partment, the early T cell activation by weak agonist liga-
tion is modestly affected by the C  FG loop deletion as
measured by this assay.
We next examined and compared Ag-induced IFN- 
production and proliferative responses of unprimed naive
lymph node T cells from N15   and N15  .  FG mice.
As shown in Fig. 6 B, when incubated for 48 h with VSV8
prepulsed EL-4 cells, both the N15   and N15  .  FG
lymph node T cells secrete IFN-  into the culture superna-
tant at each peptide concentration tested (10 5–10 9 M).
Figure 5. Decreased apoptotic cell death in thymocytes of the
N15  .  FG mice. 7-wk-old N15   and N15  .  FG mice were in-
jected intravenously with 0.5  g of VSV8 cognate peptide in 0.1 ml PBS.
18 h later, thymocytes were counted and analyzed by flow cytometry for
DNA content and annexin V staining to detect apoptotic cells. Treatment
of the N15   mouse with VSV8 resulted in an dramatic reduction of thy-
mocyte number (without VSV8, 2.07   107 cells/mouse; with VSV8,
0.26   107 cells/mouse). By contrast, the N15  .  FG mouse showed
no significant changes in the absolute number of thymocytes (without
VSV8, 10.4   107 cells/mouse; with VSV8, 10.6   107 cells/mouse) or
their subset distribution after VSV8 injection. (A) Subdiploid DNA-con-
taining thymocytes are decreased in the N15  .  FG mice. After fixation
and permeabilization, total thymocytes from N15   and N15  .  FG
mice with or without VSV8 injection were stained with PI and assayed by
flow cytometry. The histograms of DNA content on the total thymocytes
are shown. The numbers represent the percentages of subdiploid DNA-
containing apoptotic thymocytes. (B) Annexin V–positive thymocytes are
decreased in the N15  .  FG mice. Total thymocytes from N15   and
N15  .  FG mice with or without VSV8 injection were stained with
FITC-conjugated annexin V and assayed by flow cytometry. Dead cells
were gated out using PI to reveal the proportion of live thymocytes under-
going early stages of apoptosis. The histograms of annexin V staining on
the PI-negative live thymocytes are shown. The numbers represent the
percentages of annexin V  apoptotic thymocytes.1427 Sasada et al.
However, the values of IFN-  secreted from N15  
lymph node T cells are higher than those from N15  .-
  FG T cells at 10 5–10 8 M VSV8. In fact, compared
with N15   T cells, the dose–response curve from
N15  .  FG lymph node T cells is shifted to the right by
a factor of 100–1,000. Furthermore, when incubated with
EL-4 cells prepulsed with the weak agonist L4, the N15  
T cells can produce readily detectable amounts of
IFN-  at a peptide concentration of 10 4 M. In contrast,
N15  .  FG lymph node T cells cannot induce IFN- 
production after L4 stimulation at any peptide concentra-
tion tested (Fig. 6 B). Similarly, as shown in Fig. 6 C, sig-
nificant differences are also observed in the IL-2–dependent
proliferative responses of the N15   and N15  .  FG
lymph node T cells after stimulation with antigenic pep-
tides as assessed by [3H]thymidine incorporation. When
N15   and N15  .  FG lymph node T cells are cocul-
tured with irradiated EL-4 cells prepulsed with VSV8 for
48 h, the amounts of incorporated [3H]thymidine in
N15  .  FG lymph node T cells are clearly less than
those in N15   T cells at peptide concentrations from
10 6 to 10 10 M (Fig. 6 C). In addition, compared with
N15   T cells, N15  .  FG lymph node T cells show
significantly decreased proliferative responses to L4 stimula-
tion at peptide concentrations from 10 4 to 10 6 M, with
the dose–response curves from N15  .  FG lymph node
T cells shifted to the right by a factor of 10–100 (Fig. 6 C).
Collectively, these results clearly demonstrate that re-
sponsiveness to antigenic peptides is impaired in the
N15  .  FG T cells as determined by peptide antigen-
specific induction of proliferation and cytokine production.
Discussion
In this study, we generated a TCR   chain mutant
(N15  FG) in which the entire C  FG loop was deleted.
The N15  FG construct or the normal N15 wt cDNA
was then introduced as a transgene into mice and differenti-
ation/functional analysis of thymocytes conducted on the
H-2b background. While N15  FG facilitated pre-TCR
activity (Fig. 3, and Table I), our analysis reveals a distinct
phenotype with respect to effects of the   FG mutation on
further thymocyte maturation. N15  FG tg mice show a
statistically significant increase in CD8  SP thymocytes and
lymph node T cells (Table I) in association with alteration
of endogenous V  repertoires (Table II). These results im-
ply that, in balance, enhanced positive selection is favored
over negative selection. Given the potential confounding
effects of repertoire alteration, we subsequently restricted
V  expression to that of the N15   subunit on a RAG-2 / 
background in a second set of animals. Thus, N15  
TCR tg RAG-2 /  and N15  FG tg RAG-2 /  mice
were crossed to generate N15   RAG-2 /  and N15  .-
  FG RAG-2 /  littermates. N15  .  FG tg RAG-
2 /  mice were striking with regard to an 8–10-fold in-
crease in thymocyte cellularity as a consequence of an increase
in DP thymocytes without alteration in cell numbers of DN
or CD8  SP compartments (Fig. 4). This increase was due
to reduced negative selection with decreased hypodiploid
cellular DNA content constitutively as well as following
in vivo VSV8 cognate peptide injection in N15  .  FG
tg RAG-2 /  compared with N15   tg RAG-2 /  H-2b
mice (Fig. 5). Annexin V staining further confirmed the re-
Figure 6. Impaired IFN-  production and proliferation upon Ag-
triggered stimulation of naive T cells in the N15  .  FG mice. (A)
Lymph node T cells (1   105 cells) from 8–11-wk-old N15   and
N15  .  FG mice were stimulated in vitro with varying molar concen-
trations of VSV8, L4, or K1 peptide, using irradiated EL-4 cells (2   104
cells) as H-2Kb-bearing APCs. After 18 h of culture, cells were stained
with Cychrome-anti-CD8, PE-anti-CD25, and biotin-anti-CD69 followed
by FITC-streptavidin. Gated CD8  cells were analyzed and the percent-
ages of CD25- or CD69-positive cells were determined by flow cytome-
try. The data on CD69 expression only are shown but staining with anti-
CD25 mAb showed similar results. (B) Lymph node T cells (1   105 cells)
from 8–11-wk-old N15   and N15  .  FG mice were incubated with
the indicated concentrations of VSV8 and L4 and irradiated Kb-bearing
EL-4 cells (2   104 cells). 48 h later, supernatants were assayed for IFN- 
production. Mean of duplicate cultures is shown. (C) Lymph node T cells
(1   105 cells) from 8–11-wk-old N15   and N15  .  FG mice were
incubated in vitro with the indicated concentrations of VSV8 and L4, us-
ing irradiated EL-4 cells (2   104 cells) as H-2Kb-bearing APC. 48 h later,
[3H]TdR was pulsed for 18 h and T cell proliferation was judged by
[3H]TdR incorporation. Mean of duplicate cultures is shown. Results are
representative of four independent experiments.1428 C  FG Loop in TCR Function
duced apoptosis in N15  .  FG RAG-2 /  versus
N15   RAG-2 /  mice.
At first glance, these data may appear in conflict with earlier
studies by Degermann et al. (43), whose findings indicated
that a TCR   chain lacking the identical solvent-exposed
C  FG loop supported normal    T cell development
in tg mice as well as normal function in cell transfectants.
Their   chain was derived from the 14.3.d TCR specific for
HA110–119 PR8 influenza hemagglutinin peptide complexed
with I-Ed and comprised of V 8.2 and J 2.1 segments, un-
like the N15  FG chain derived from the VSV8/Kb-specific
N15 CD8  SP CTL encoded by V 5.2 J 2.6 segments. In
14.3.d   FG tg mice, superantigen-induced proliferation,
anti-H-2d CTL effector function, or helper T cell responses
for anti-hapten antibody production were essentially nor-
mal. However, given that in the 14.3.d   FG tg mice, en-
dogenous TCR   subunits pair with the introduced  
transgene product, the biologic system can readily overcome
any deficiency mediated by the   FG deletion. Hence,
polyclonal T cell responses are not a sensitive indicator of
the functional consequences of the C  FG loop deletion.
Consistent with this notion, additional studies by the same
authors in 14.3.d   FG mice show that    T cells coex-
pressing NK1.1 are severely depleted (44). This is particu-
larly noteworthy, as  80% of NK1.1 T cells express the
invariant (V 14-J 281) segment required for their develop-
ment (45). Thus, even in the RAG-2 /  background, a
near single TCR specificity is generated with regard to
NK1.1 T cells, permitting the effects of the C  FG loop de-
letion to be recognized. Our results, in conjunction with
those of Degermann, imply that the C  FG loop is func-
tionally significant for immune recognition-based signaling
by both conventional    T cells and NK1.1 T cells of
pMHC and CD1 specificities, respectively.
Prior mAb epitope mapping analysis showed that one of
the two CD3  subunits within a TCR complex is in close
proximity to the TCR C  chain FG loop whereas the sec-
ond CD3  subunit lies elsewhere. Crystallographic analysis
of the N15 TCR    heterodimer reveals a striking asym-
metry within the constant domain module such that virtu-
ally half of the C  domain’s ABED surface is exposed, yet
uninvolved in C  domain contacts. This asymmetry creates
a cavity beneath the   chain with the C  ABED surface as
a ceiling and the plasma membrane as the floor. The two
protruding C  loops (CD loop and EF loop) plus one C 
(N185) and two C  (N121, N186) glycans form one side-
wall while the C  FG loop and one C  (N236) glycan
form the second wall of this cave. In structural terms, the
role of this extensive FG loop is to further rigidify the in-
terface between V  and C  domains, thereby limiting the
lateral movement of V . In addition, careful analysis of the
C  FG loop in several TCR structures (22, 28, 30, 46) re-
veals conservation of the three-dimensional structure of the
loop, the adjacent C  domain and the cave of both
pMHCI- and pMHCII-restricted TCRs in human (29, 30)
and mouse (22, 28). Such conservation implies an impor-
tant role for this structural element on both CD4  and
CD8  SP T cells. By forming a side wall of the cavity into
which a CD3  subunit of one CD3 heterodimer can insert,
the C  FG loop presumably stabilizes the interaction be-
tween CD3  and the Ti   heterodimer. Not surprisingly,
therefore, immunoprecipitation studies using the CD3  
dimer-specific mAb 7D6 with N15   and N15   FG
transfectants reveals a markedly weakened association of
CD3   with the TCR    heterodimer and CD3  in
N15   FG T cells (unpublished data). It is further note-
worthy that the loop is negatively charged, perhaps influ-
encing the electrostatics of the TCR surface in a manner
similar to an N-linked glycan. Antedating the evolution of
the FG loop in higher vertebrates, such a glycan localizes to
the same region in primitive species (shark, chicken and
axo; data not shown). Although the mouse has an adjacent
N-linked glycan as well as the elongated FG loop in its
TCR structure, both are not essential since the human
TCR lacks an N-linked attachment site.
With these details in mind, we note that the TCR is a
largely rigid structure: one component consists of the FG
loop-“reinforced” V -C  extracellular segment associated
via an extensive ( 2400 Å2) buried surface interface with
the C  domain of the TCR  subunit, a second compo-
nent. The C -C  interface contains multiple rigidifying
salt bridges. Hence, the V -C -C  domains form a single
conformationally rigid module. This V -C -C  module
in turn is noncovalently associated with the CD3   and/or
CD3   heterodimers such that the glycosylated CD3  and
CD3  subunits extend away from the TCR heterodimer
while the two nonglycosylated CD3  subunits are proxi-
mal. NMR structural studies show that CD3  and CD3 
(and by extension CD3  ) adopt C2-set IgSF folds, form-
ing a stable heterodimeric complex by parallel strand pair-
ing (G strand) and hydrophobic interaction (24). The
CD3 -CD3  G strand pairing presumably creates a rod-
like connector, permitting displacement of transmembrane
helices of CD3   and CD3   upon TCR triggering, lead-
ing to intracellular kinase-dependent events and resulting in
T lineage activation. Removal of the C  FG loop, by elim-
inating one wall of the cave in the C  domain would re-
duce one key component of the rigidifying architecture
such that signaling might be impaired. Hence the altered
negative selection in DP thymocytes of the N15  .  FG
animals and the reduced capacity of their CD8  SP lymph
node T cells to proliferate to cognate antigens and APL are
anticipated sequelae. That polyclonal thymocytes and    T
cells in   FG tg mice (i.e. RAG-2 / ) can overcome this
block, implies either that compensatory adaptations in the
TCR  subunit or elsewhere readily occur or that addi-
tional protein interactions among TCR subunits (for exam-
ple, within their transmembrane segments) maintain TCR-
based signaling even in the absence of FG loop constraint.
These possibilities are not mutually exclusive.
The prominent effect of the   FG transgene in
N15  .  FG RAG-2 /  mice is the marked inefficiency
of negative selection processes compared with that of
N15   RAG-2 /  mice. Interestingly, the C  FG loop
deletion impairs negative selection without diminishing the
capacity of DP thymocytes to differentiate to CD8 SP thy-1429 Sasada et al.
mocytes; hence, the number of CD8  SP thymocytes in
N15  .  FG RAG-2 /  H-2b and N15   RAG-2 / 
H-2b littermates is identical. In general, pMHC ligands of
stronger affinity are negatively selecting while those with
weaker affinity for a given TCR are positively selecting
(for reviews, see references 47 and 48). Given that the C 
FG loop deletion will reduce rigidification and likely atten-
uate signaling from negatively selecting ligands, this result is
not surprising. In contrast, positive selection must not be
attenuated below a threshold required for initiating effec-
tive survival signaling. As other studies have demonstrated
that positive and negative selection are under the control of
different signaling pathways (for reviews, see references 38
and 49), this differential concept is entirely tenable. Never-
theless, in N15  .  FG RAG-2 /  mice, the numbers of
CD8  SP lymph node T cells are somewhat reduced com-
pared with N15   RAG-2 /  mice on the same H-2
background. This observation in conjunction with in-
creased HSA and PNA staining of CD8  SP thymocytes in
N15  .  FG RAG-2 /  mice (data not shown) suggests
that positive selection may not be entirely unaffected by
the C   FG mutation.
The pre-TCR consists of a TCR  chain disulfide-
bonded to the thymus-restricted pT  subunit expressed on
DN thymocytes in association with CD3  heterodimers
and CD3  homodimers (34, 50). Although the single Ig-
like ectodomain of pT  bears only 12% homology to TCR
C , key residues participating in the formation of the rigid
interface between C  and C  are preserved (22). This
structural conservation suggests that the heterodimeric in-
terface of pT -C  is similar to the interface of C -C .
From this conserved feature, we have inferred that a CD3 
heterodimer slots into a pre-TCR cave comparable to that
created within the TCR. That a CD3  knockout mutation
disrupts pT  function (51) is consistent with this view. Fur-
thermore, given that a CD3  knockout also disrupts pre-
TCR function (52), it is tempting to speculate that CD3  
is the cave-associated CD3  heterodimer. Limited glyco-
sylation of CD3  relative to CD3  allows for ready modeled
docking of the CD3   but not CD3   heterodimer at this
cavity while still accommodating H57 mAb binding (un-
published results). Three additional facts also support the
presumptive CD3   localization. First, it is known from
chain association studies that CD3   pairs with TCR 
whereas the CD3   heterodimer binds to TCR  (53).
Second, these experiments show that CD3  and TCR  in-
teract via their respective ectodomains whereas the associa-
tions of the CD3 ,  , and   components with TCR   and
  are mediated via their transmembrane regions. Third,
chemical cross-linking experiments in man and mouse im-
ply proximity of TCR  and CD3  (18, 54). The above re-
sults notwithstanding, verification of these predictions still
requires definitive structural elucidation.
The inability of the C  FG loop deletion to influence
the function of the pre-TCR is consistent with recent
transgenic experiments in the pT  /  background: pT 
constructs lacking both the ectodomain and much of the
cytoplasmic tail still support pre-TCR function (55). These
data imply that pT  stabilizes the pre-TCR predominantly
via transmembrane interactions, with CD3  heterodimer
association not singularly dependent on the cave for pre-
TCR function. Further support for this notion comes from
three other observations: (a) mice transgenic for a TCR 
chain lacking the V  domain support DN to DP transition
(56); (b) pT  and TCR  chains lacking their respective Ig-
like domains still facilitate thymic differentiation in RAG-
deficient mice (57); and (c) mutational analysis of the two
tyrosines in the TCR  transmembrane region show that
even conservative tyrosine to phenylalanine changes disrupt
thymocyte survival, proliferation, and differentiation (58),
further underscoring the importance of the transmembrane
segment for pre-TCR function. Alterations within the
TCR ectodomains are less well tolerated with regard to
  TCR function, significantly impinging on TCR activ-
ity. For example, C  FG loop deletion reduces the effi-
ciency of negative selection in N15  .  FG RAG-2 / 
mice. Mutations of the TCR  chain connecting peptide
profoundly affect positive selection. The latter occurs
through attenuation of ERK activation and a reduction of
activated lck, Zap-70, phospho-CD3 , and phospho-LAT
within lipid rafts (59). A similar phenotype with equivalent
biochemical signaling aberrations is observed in CD3  / 
mice (60). If CD3   maps to the TCR  side and CD3  
to the TCR  side of the    TCR complex, these findings
can be rationalized.
In N15  .  FG RAG-2 /  H-2b mice, the level of
N15 TCR as judged by both MR9.4 (anti-V 5) or R53
(anti-V  clonotype) is virtually identical to that found on T
cells of N15   RAG-2 /  H-2b mice. However, in the
former case,  50% of TCRs are wild-type and 50% incor-
porate the mutant   FG subunit. Yet mature CD8  SP T
cell function is significantly reduced in N15  .  FG
RAG-2 /  mice. Thus, despite half of the TCRs being
wild-type in structure, functional activation of these T cells
vis-a-vis cytokine production or proliferation is dramati-
cally reduced. In contrast, tetracycline regulatable TCR
transgene expression shows that cells expressing as few as
1/20 of the normal levels of TCRs preserve their functional
activity (61). Thus, paradoxically, the presence of TCRs
with the   FG subunit is more detrimental to TCR-trig-
gered activation than the complete absence of wild-type
TCRs. Although the basis for this disparity remains to
be elucidated, N15  .  FG TCRs may dysregulate wt
TCRs by activating inhibitory pathways (phosphatases or
others) in the absence of productive stimulation.
These data indicate an important functional role for the
C  FG loop in both thymic negative selection and mature
T cell activation, T lineage activities requiring threshold
stimulation to achieve a stringent set point. On the other
hand, positive selection is only modestly altered. In view of
evidence that positive selection requirements vis-a-vis
pMHC interaction are less arduous with regard to affinity
and avidity than those for negative selection (47, 48), this
result is perhaps not surprising. Thus, attendant reduction
in signaling strength through TCRs incorporating mutant
  FG subunits may still be sufficient to achieve the more1430 C  FG Loop in TCR Function
“relaxed” set point threshold for successful positive selec-
tion. Apparently, structural features of the    TCR have
evolved to facilitate the “multi-tasking” requirements of
TCR signaling function during development and mature T
cell function. In sum, TCR -linked transduction events
are more critically involved in negative selection while it
appears that TCR -linked transduction processes are key
for positive selection.
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